Panel-Reactive Screening and Treatment Practices Following Bridge to Transplantation Ventricular Assist Device Placement

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1813-1815

  Freudenberger, R S ^a   Tawfik, I ^a   Shinnar, M ^a   Pendergast, T ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PANEL REACTIVE ANTIBODY;

ANTIBODY SCREENING; ARTICLE; HEALTH PROGRAM; HEALTH SURVEY; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; IMPLANTATION; MEDICAL PRACTICE; PRIORITY JOURNAL;

ADULT; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEART VENTRICLES; HEART-ASSIST DEVICES; HISTOCOMPATIBILITY TESTING; HUMANS; LUNG TRANSPLANTATION; QUESTIONNAIRES;

EID: 67249099464     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.062     Document Type: Article

References (10)

1. Massad M.G., Cook D.J., Schmitt S.K., et al. Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg 64 (1997) 1120
2. Williams G.M., Hume D.M., Hudson R.P., et al. "Hyperacute" renal-homograft rejection in man. N Engl J Med 279 (1968) 611
3. Rose E.A., Pepino P., Barr M.L., et al. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant 11 (1992) S120
4. Smith J.D., Danskine A.J., Laylor R.M., et al. The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. Transpl Immunol 1 (1993) 60
5. Stringham J.C., Bull D.A., Fuller T.C., et al. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization. J Heart Lung Transplant 18 (1999) 160
6. DeNofrio D., Rho R., Morales F.J., et al. Detection of anti-HLA antibody by flow cytometry in patients with a left ventricular assist device is associated with early rejection following heart transplantation. Transplantation 69 (2000) 814
7. Itescu S., Shuster M., Burke E., et al. Immunobiologic consequences of assist devices. Cardiol Clin 21 (2003) 119
8. Goffinet J., and St Pierre Schneider B. Preformed anti-human leukocyte antigen antibodies jeopardize cardiac transplantation in patients with a left ventricular assist device. Heart Lung 31 (2002) 122
9. Tsau P.H., Arabia F.A., Toporoff B., et al. Positive panel reactive antibody titers in patients bridged to transplantation with a mechanical assist device: risk factors and treatment. Asaio J 44 (1998) M634
10. Drakos S.G., Stringham J.C., Long J.W., et al. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. J Thorac Cardiovasc Surg 133 (2007) 1612